Press Releases

All Releases
View Summary KaloBios Reports Second Quarter Financial Results and Provides Clinical Update
Aug 10, 2015
PDF 36.7 KB Add to Briefcase
View Summary KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia
Jul 29, 2015
PDF 36.9 KB Add to Briefcase
View Summary KaloBios Regains Compliance with NASDAQ Minimum Bid Price Requirement
Jul 29, 2015
PDF 35.4 KB Add to Briefcase
View Summary KaloBios Announces Shareholders and Board of Directors Approval of Reverse Stock Split
Jul 13, 2015
PDF 28.8 KB Add to Briefcase
View Summary KaloBios to Present at the JMP Securities Life Sciences Conference
Jun 17, 2015
PDF 28.5 KB Add to Briefcase
View Summary KaloBios Appoints Ronald A. Martell Executive Chairman
May 28, 2015
PDF 28.9 KB Add to Briefcase
View Summary KaloBios Reports First Quarter 2015 Financial Results
May 11, 2015
PDF 34.1 KB Add to Briefcase
View Summary KaloBios Elects Ronald A. Martell to Board of Directors
Apr 22, 2015
PDF 28.5 KB Add to Briefcase
View Summary KaloBios to Present at the 14th Annual Needham Healthcare Conference
Apr 6, 2015
PDF 29.0 KB Add to Briefcase
View Summary KaloBios Reports Fourth Quarter 2014 Financial Results
Mar 16, 2015
PDF 42.6 KB Add to Briefcase
View Summary KaloBios Announces Upcoming Investor Conference Participation
Feb 3, 2015
PDF 30.5 KB Add to Briefcase
View Summary KaloBios Announces Retirement of David W. Pritchard, President and Chief Executive Officer
Jan 8, 2015
PDF 29.9 KB Add to Briefcase
View Summary KaloBios Reports Top-Line Data for Phase 2 Study of KB001-A to Treat Pseudomonas Aeruginosa Lung Infections in Cystic Fibrosis Patients
Jan 6, 2015
PDF 32.8 KB Add to Briefcase
View Summary KaloBios Elects Robert A. Baffi, BioMarin Senior Executive, to Board of Directors
Dec 1, 2014
PDF 29.2 KB Add to Briefcase
View Summary KaloBios Announces Upcoming Scientific and Investor Conference Participation
Nov 11, 2014
PDF 30.2 KB Add to Briefcase
View Summary KaloBios Reports Third Quarter Financial Results
Nov 6, 2014
PDF 35.6 KB Add to Briefcase
View Summary Publication by KaloBios and Collaborators Shows EphA3 as Target for Highly Selective Anticancer Therapy
Aug 14, 2014
PDF 29.8 KB Add to Briefcase
View Summary KaloBios Provides Clinical Update and Reports Second Quarter Financial Results
Aug 7, 2014
PDF 36.7 KB Add to Briefcase
View Summary KaloBios Provides Update on KB001-A Partnership and Clinical Status
Jul 28, 2014
PDF 31.9 KB Add to Briefcase
View Summary KaloBios to Present at 9th Annual JMP Securities Healthcare Conference
Jun 11, 2014
PDF 35.8 KB Add to Briefcase
Showing 1-20 of 71 Page: 1 2 3 4  Next 20
Add to Briefcase = add release to Briefcase

Shareholder Tools

Search Investor Relations

You are now leaving this website. If you would like to continue, click Continue.
CancelContinue